Latest Stock Market News

For promoters, Sebi said the lock-in requirement for allotment up to 20 per cent of the post issue paid-up capital has been reduced to 18 months from the existing 3 years.

The regulator has prescribed certain conditions for offer-for-sale (OFS) to the public in an IPO, where draft papers are filed by an issuer without a track record.

the proceeds of the loan shall be utilised towards capital expenditure for ongoing/new capacity addition programme including renewable energy projects, coal mining & washeries, refinancing of existing ECBs/rupee loans availed domestically for capex etc

After two years of strong outperformance of value-style equities, the key question for investors is can the rally continue for a third year in a row? In our view, fundamental drivers remain in place for the continuation of value outperformance.

Majority of exchanges have demanded clarity about the taxation over the income earned from the crypto assets and GST rules implemented on the trading platforms to ease the operations for all the parties involved

“NII is expected to grow 33 per cent YoY to Rs 5,700 crore. NIMs are expected to rise with both consumer and mortgage book seen witnessing strong growth,” said analysts at ICICIdirect.

STT was introduced in 2004 when long term capital gains tax (LTCG) was abolished by the then finance minister P Chidambaram. STT is collected upfront by the exchanges making it easier for the government to collect them. In the 2018 budget, LTCG of 10 per cent for gains over Rs 1 lakh was introduced, but STT wasn’t reduced.

“Overall, the 2022 outlook remains constructive wherein the terms of returns may not be as strong as last year but overall we would still expect healthy returns going ahead.”

The Nifty Pharma index closed 0.73 per cent down at 13862.45.

As of 30-Sep-2021, promoters held 62.55 per cent stake in the company, while FIIs held 13.53 per cent and domestic institutional investors had 7.64 per cent.